Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk.
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, B18 7QH, UK.
Deirdre A
DA
Lane
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, B18 7QH, UK. Electronic address: g.y.h.lip@bham.ac.uk.
Gregory Yh
GY
Lip
D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D011725:Pyridines; D000069604:Dabigatran